Behind the Scenes at the Newfoundland and Labrador Prescription Drug Program (NLPDP) Issue - H2 antagonist - Document - PDFSEARCH.IO

First Page	Meta Content
	Behind the Scenes at the Newfoundland and Labrador Prescription Drug Program (NLPDP) Issue #7 (December[removed]Proton Pump Inhibitors - Policy Changes Currently NLP DP c onsiders five PPIs for coverage under Special Autho Add to Reading List Document Date: 2010-04-07 12:30:24 Open Document File Size: 148,59 KB Share Result on Facebook Currency USD / / IndustryTerm treatment of gastroesophageal reflux disease / healthcare dollars / / MedicalCondition GERD / ZollingerEllison syndrome / gastroesophageal reflux disease / / Position physician / Atlantic Expe rt Advisory Com mittee / / Product Pegasys / Meloxicam / Mirtazapine / Pariet 10mg / Viread / Iressa / Ophthalmic Solution Genteal Eye Gel Vitamin B-12 100mcg/ml Injection / Omeprazole / Sodium Chloride / Prevacid / Risperdal / Reyataz / Clozaril / / ProvinceOrState Newfoundland / / URL www.ccohta.ca / / SocialTag Organic chemistry Sulfoxides Benzimidazoles Medicine Omeprazole Rabeprazole Lansoprazole Vitamin B12 H2 antagonist Chemistry

Behind the Scenes at the Newfoundland and Labrador Prescription Drug Program (NLPDP) Issue #7 (December[removed]Proton Pump Inhibitors - Policy Changes Currently NLP DP c onsiders five PPIs for coverage under Special AuthoAdd to Reading List